PRL-8-53 10 mg, 60 caps

PRL-8-53 10mg - support for memory and learning processes

PRL-8-53 (chemical name: methylaminoethyl benzoate) is a laboratory compound created in the 1970s as part of research work on cognitive processes and was first synthesized by Nikolaus Hansel of Creighton University. The described observations on memory were reported in laboratory studies.

The authors of these studies believe that a potential mechanism of action of PRL-8-53 may involve its effects on neurotransmitters in the brain (especially acetylcholine). In the scientific literature, acetylcholine activity is sometimes linked to learning processes and memory, but this does not determine a clear effect after the use of this compound.

One of the frequently discussed research hypotheses in the case of PRL-8-53 is the analysis of its potential effects on the dopaminergic system. (research)

The literature has also described limited human data reporting changes in verbal memory and learning test scores. (research)

It's always important to remember that substances labeled as nootropics or research drugs, no matter how innocuous they may seem, can profoundly alter cognitive function, for both good and bad.

Even modulating the cholinergic system, as is the case with PRL-8-53, can have adverse effects in some individuals and lead to mild headaches, increased anxiety, and perhaps even changes in other neurotransmitters such as serotonin production.

BIOLAB PRL-8-53 10 mg with laboratory-confirmed content — the test showed 10.81 mg/cap., which confirms conformity with the declaration.